= 9.4 X 10-4 ); group III is 55.9% (Pem = 8. 1 X 10-8) compared with 24.1 % in controls. Thus, DQB 1 *03 may be a general marker allele for alopecia areata.
A very e arly age of onset of the first patch of AA was found in group III patients : by age 10 years, 45% of patients in group III developed their first patch of AA as compared with only 10% of group II patients. However, by the age of 40 year s the majority of both group II and group III patients had their first patch of AA: 96% of group III patients and 77% of group II patients. Age of onset also correlated with the family history of AA: 37% of patients who developed their first patch of AA by age 30 ye ars had family members with AA whereas only 7.1% of patients had family histories of AA when the first patch appeared after age 30. From all these data, it appears that early onset of AA is associated with severity of disease, long-standing disease, and familial history of AA.
We hypo thesize that failure in some previous studies to achieve significance for DR and DQ antigens after appropriate statistical correction could be due in part to the inappropriate grouping of patients or to the conglomeration of all patients into In conclusion, the two clinical forms of alopecia areata, long standing AT/AU, and long-standing patchy AA, can be distin guished by the singular association of AT/AU patients with the HLA class II antigens DRB1 *1104 (DR11) and DQB1 *0301 (DQ7). These antigens may represent a genetic marker for those patients who are more susceptible to severe and long-lasting disease. In addition, 79% of all patients showed an association with the generic antigen DQBl *03 (DQ3), which may represent a generalized susceptibility gene for alopecia areata. This work was s"ppO/ted ill pmt by grallts jimn The Upjohn CompallY.
6S DUVIC ET AL
A lopecia areata (AA) has been associated with other autoimmune diseases and is characterized by an inflammatory T-cell infiltrate with the production of cytokines around affected hair fo llicles. The target for the T cell is at this time unknown. There is a wide spectrum of disease actIvIty ranging from one patch of alopecia with total regrowth to persistant loss of all scalp and body hair. Previous studies by us and by others have suggested that there is an association of alopecia areata with genes on chromosome 6 in the major histocompatibility locus (HLA). In particular, DR4 and 5 alleles are increased in unrelated AA patients versus controls [1] . Although most cases of alopecia areata occur sporadically, there are reports of familial association in 10-47% of affected patients and there are cases of discordant and concordant monozygotic twins [2] . This suggests that certain genes may be responsible for a genetic predisposition for AA and that environmental triggers may also be important. The purpose of these studies was to further define the immunogenetic basis for AA.
MATERIALS AND METHODS
Patients with AA «75% hair loss) or alopecia totalis (AT >75% hair loss)/alopecia universalis (AU, total scalp and partial body hair loss) and controls signed consents for venopuncture and HLA typing of peripheral blood lymphocytes. Individual patients were ascertained from dermatology clinic populations. Families were ascertained from the National Alopecia Areata Foundation newsletter and were examined by a dermatologist.
HLA-DR and -DQ alleles were first typed by restriction fragment-length polymorphism patterns according to the Eighth International Histocompat ibility Workshop [1]. HLA-DR, -DQ, and -DP alleles were ascertained by peR amplification and dot blotting with allele-specific oligos according to the Eleventh Workshop [3] . Linkage to DQ was by the method of Ott using LINKAGE programs [4] .
RESULTS
Compared to 78 normal controls, unrelated Caucasian AA patients (36 with AA and 50 with AT/AU) had increases in the phenotype frequencies ofDR4 and associated DQw8 as well as increases in the genotype frequencies of DR4 and DR5 (DRw11). Sixty-one percent of all AA patients had DR4 and/or DR5 alleles versus 40% of controls. A highly negative association with the DRB3 allele DRw52a was also detected [1] .
In a second study in which allele-specific oligo typing was performed in 85 unrelated Caucasian AA patients, there was a significant increase in DQB1*301, 41% in all patients, 47% in AU/ AT patients, and 27% in controls. Furthermore, DQB1 *301 alleles (301, 302, 303) were present in 80% of all patients and 92% of AT/AU patients (ODDs ratio = 12.14, P = 0.00003, corrected). DQB1 *06 was decreased to 32% of all patients versus 56% of controls (ODDs ratio = 0.37, P = 0.0045, corrected). Subtyping of DR11 alleles revealed that the DRB1 *1104 allele was fo und in six of seven (86%) DR11 patients with patchy AA (ODDs ratio, 16.25) and in five of 13 (55%) AT/AU patients who were DR11, versus 27% of controls. No association was found with DP alleles or with DQA alleles [3] .
In a third study, we have analyzed 29 multiplex fa milies with 244 total individuals and 77 affected individuals. Vitiligo, thyroid disease, and diabetes were the most commonly reported auto immune diseases in these affected individuals and their family 
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members. There were five fa milies with three generations affected, three sets of identical twins, one set of fraternal twins, and several affected cousins. In two sets of identical twins there was discordance for AA.
We assumed a genetic model of autosomal dominance with incomplete penetrance [2] , a gene frequency of 1%, a sporadic lifetime risk of 0.6%, and a total population susceptibility of 1 %. The lifetime penetrance was set at 20% with 10% penetrance by age 30. Analysis for linkage with DQ in these 29 multiplex families gave a positive LOD score of 1.05, with theta = 0.07. This analysis did not consider the HLA association in unrelated individuals, which would be expected to significantly increase the LOD score.
CONCLUSIONS
AA patients have a significant increase in certain HLA-D locus antigens compared to race and ethnic matched controls. The HLA-DR4 and DR5 [1] alleles previously shown to be associated with AA are in linkage disequilibrium with HLA-DQ alleles, which are more significantly associated with AA. Among DR11 alleles, DR1 *1104 is most significantly associated with patchy AA (ODDs ratio = 16). DQB1 *03 alleles are strongly associated with AA and AT/AU with an ODDs ratio of 12. These ODDs ratios are noteworthy considering values for other autoimmune diseases including insulin-dependent diabetes mellitus with DR4 (ODDs ratio = 4-6), Celiac disease with DR3 and OR7 (RR = 8-12), and pemphigus with DR4 (RR = 24) [3] .
Whereas disease associations are done in unrelated individuals, family studies are necessary to detern�ine whether a particular gene is linked to or causes a specific disease. Linkage is a measure of recombination frequency between a trait such as AA and a genetic locus such as HLA-DQ. These preliminary studies suggest that there may be linkage between AA and genes of the DQ locus or its neighbors.
Autoimmune diseases are likely to involve input from several different genes, including HLA antigens. It is likely that there are environmental fa ctors (drugs, infections, chemicals, etc.) that will trigger an autoimmune disease in individuals with the proper genetic susceptibility. Other genes are likely to be needed to produce the effect and still others to cause disease persistence or regression. Because antigen presentation is governed by interactions between cells bearing HLA molecules and the T-cell receptor, susceptibility genes are likely to involve these specific molecules. In particular, we speculate that the proline at position 55 of the DQB chain shared by the OQB*03 alleles may be important for the presentation of an unknown AA-associated antigen [3] . Further research to define other associated genes, such as the T-cell receptor chains, immunoglobin subtypes, and cytokines, is needed to work out the pathogenesis of AA.
